For the 2018 third quarter, the company reported net sales of $30.1 million, up 20.2% from $25.1 million in the prior-year period. According to the announcement, the increase was primarily due to year-over-year revenue gains from IntriCon’s largest medical customer and growth in its value-based hearing healthcare business.
Read More
Compared to the patients without hearing loss, patients with the condition generated nearly 26% more in total health care costs within two years, a gap that widened to 46% by 10 years, amounting to $22,434 per individual ($20,403 incurred by the health plan, $2,030 by the individual in out-of-pocket costs).
Read More
Researchers wanted to see whether machine learning algorithms could pick out patterns within the raw acoustical data that indicated what the crowd was doing at a given time, thereby providing clues as to what was happening in the game itself.
Read More
These preclinical data, demonstrating the potential of intratympanic BDNF to repair cochlear synaptopathy—an underlying cause of hearing loss including speech-in-noise hearing difficulty—are being presented as part of the Society for Neuroscience (SfN) Annual Meeting in San Diego, November 3-7, 2018.
Read More
An application to the European Commission for approval of an $8 billion merger between hearing aid manufacturers Widex and Sivantos has been withdrawn, according to a “Reuters” report.
Read More
A US District Court has awarded $268.1 million in damages against Cochlear Ltd as part of a patent infringement lawsuit filed by the Alfred E. Mann Foundation for Scientific Research and Advanced Bionics LLC.
Read More
The new service is designed to increase access to hearing care over distance by helping to enable remote fine-tuning of Phonak Audéo Marvel hearing aids from virtually anywhere in the world.
Read More
InnerScope and Erchonia are reported to have received approval under FDA regulations from an Institutional Review Board (“IRB”) for the initial clinical trial of the effect of Erchonia’s low-level laser therapy technology on the relief of tinnitus symptoms.
Read More
On October 5, the FDA granted De Novo status to Bose Corporation for a self-fitting hearing aid for mild-to-moderate hearing loss.
Read More
A presentation demonstrating the therapeutic potential of OTO-413, a sustained-exposure otic formulation of brain-derived neurotrophic factor (BDNF), for the repair of cochlear synaptopathy in speech-in-noise hearing difficulties has been selected by SfN as a Neuroscience 2018 Hot Topic.
Read More
Shennib brings over 30 years of experience in healthcare innovations, starting his career in implantable cardiac pacing, and later taking leading roles with several hearing aid manufacturers including ReSound and InSound Medical, where he invented and developed the Lyric™ hearing device.
Read More
The organizations plan to meet quarterly for the foreseeable future and gradually introduce the deliverables of their new collaboration.
Read More
Several “autoREMfit” systems have been developed to assist in hearing aid fittings. This article evaluates a new fit-to-target platform, Audioscan’s VerifitLINK, that could be integrated into any manufacturer’s software, and documents its performance in target matching during hearing aid fitting.
Read More
EUHA announced that its members have voted Beate Gromke president of the EUHA. Eva Keil-Becker will be the association’s Vice-President, and Jürgen Matthies its Vice-President and Treasurer. She succeeds Martin Blecker, who had served on the EUHA executive committee for 27 years.
Read More
Using augmented reality to make science, technology, engineering, and math content more accessible to deaf and hard-of-hearing learners in live presentation settings is the goal of a $258,000 grant from the National Science Foundation (NSF) awarded to Rochester Institute of Technology’s National Technical Institute for the Deaf (RIT/NTID).
Read More